HHLR Advisors’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-623,434
| Closed | -$3.92M | – | 71 |
|
|
2022
Q4 | $3.92M | Sell |
623,434
-176,566
| -22% | -$1.11M | 0.08% | 50 |
|
|
2022
Q3 | $8.64M | Hold |
800,000
| – | – | 0.23% | 37 |
|
|
2022
Q2 | $9.12M | Hold |
800,000
| – | – | 0.2% | 35 |
|
|
2022
Q1 | $7.29M | Hold |
800,000
| – | – | 0.15% | 38 |
|
|
2021
Q4 | $11.9M | Hold |
800,000
| – | – | 0.18% | 44 |
|
|
2021
Q3 | $20.6M | Hold |
800,000
| – | – | 0.27% | 43 |
|
|
2021
Q2 | $20.9M | Hold |
800,000
| – | – | 0.21% | 52 |
|
|
2021
Q1 | $28.2M | Hold |
800,000
| – | – | 0.28% | 40 |
|
|
2020
Q4 | $20.2M | Hold |
800,000
| – | – | 0.16% | 58 |
|
|
2020
Q3 | $30.2M | Hold |
800,000
| – | – | 0.23% | 37 |
|
|
2020
Q2 | $34.3M | Buy |
+800,000
| New | +$34.3M | 0.31% | 32 |
|